Tilray Brands (TLRY) Stock Price, News & Analysis

Company Overview

Tilray Brands, Inc. is a global consumer packaged goods company focused on cannabis, beverage alcohol, wellness and consumer products. The company develops, produces, distributes and markets a range of cannabis products, including dried flower, pre-rolls, vapes, edibles and medical cannabis products, subject to applicable regulations in the markets it serves.

Tilray also operates beverage alcohol businesses, including craft beer, spirits and other alcoholic beverages. Its portfolio has included brands such as SweetWater Brewing Company, Montauk Brewing Company and Breckenridge Distillery. In addition, the company has participated in the hemp food and wellness categories through brands including Manitoba Harvest.

Tilray was founded in 2013 and combined with Aphria Inc. in 2021, after which the combined company adopted the Tilray Brands name. The company serves customers in Canada, the United States, Europe and other international markets, with its activities varying according to local laws and regulations. Irwin D. Simon serves as Tilray Brands’ chairman and chief executive officer.

Key Stats

• Today's Range: $3.70 to $3.76
• 50-Day Range: $3.57 to $4.88
• 52-Week Range: $3.54 to $23.20
• Volume: 3.33 million shs
• Average Volume: 4.21 million shs
• Market Capitalization: $505.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.38
• Consensus Rating: Hold

Tilray Brands Stock Analysis - MarketRank™

Tilray Brands scored higher than 79% of companies evaluated by MarketBeat, and ranked 141st out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Hold

Consensus Rating

Tilray Brands has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on 1 strong buy rating, 3 buy ratings, 2 hold ratings, and 2 sell ratings.

Upside Potential

Tilray Brands has a consensus price target of $6.38, representing about 69.8% upside from its current price of $3.76.

Amount of Analyst Coverage

Tilray Brands has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Tilray Brands are expected to grow in the coming year, from ($0.42) to ($0.18) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Tilray Brands is -3.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Tilray Brands is -3.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Tilray Brands has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

14.38% of the float of Tilray Brands has been sold short.

Short Interest Ratio / Days to Cover

Tilray Brands has a short interest ratio ("days to cover") of 5.22.

Change versus previous month

Short interest in Tilray Brands has recently increased by 7.52%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tilray Brands does not currently pay a dividend.

Dividend Growth

Tilray Brands does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.02

News Sentiment

Tilray Brands has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 25 news articles for Tilray Brands this week, compared to 8 articles on an average week.

Search Interest

16 people have searched for TLRY on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

22 people have added Tilray Brands to their MarketBeat watchlist in the last 30 days. This is an increase of 214% compared to the previous 30 days.

Company Ownership

• Score: 3.7 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

3 insiders have purchased shares of Tilray Brands in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $69,225.00 in company stock, which represents 0.0135% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Tilray Brands insiders have bought more of their company's stock than they have sold. Specifically, they have bought $69,225.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

1.60% of the stock of Tilray Brands is held by insiders.

Percentage Held by Institutions

9.35% of the stock of Tilray Brands is held by institutions.

Company Calendar

• Last Earnings: 7/28/2026
• Today: 10/07/2026
• Next Earnings (Estimated): 10/08/2026
• Fiscal Year End: 5/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:TLRY
• Previous Symbol: NASDAQ:TLRY
• CIK: 1731348
• Web: www.tilray.com
• Phone: 206-432-9325
• Fax: N/A
• Employees: 3,595
• Year Founded: 2013

Price Target and Rating

• Average Price Target for Tilray Brands: $6.38
• High Price Target: $10.00
• Low Price Target: $4.50
• Potential Upside/Downside: +71.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.38
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$121.40 million
• Net Margins: -13.11%
• Pretax Margin: -9.62%
• Return on Equity: -7.76%
• Return on Assets: -5.59%

Debt

• Debt-to-Equity Ratio: 0.22
• Current Ratio: 2.21
• Quick Ratio: 1.37

Sales & Book Value

• Annual Sales: $915.45 million
• Price / Sales: 0.55
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $13.68 per share
• Price / Book: 0.27

Miscellaneous

• Outstanding Shares: 136,200,000
• Free Float: 134,025,000
• Market Cap: $505.30 million
• Optionable: Optionable
• Beta: 1.91